<DOC>
	<DOCNO>NCT01104792</DOCNO>
	<brief_summary>The objective study evaluate long-term safety , tolerability pharmacokinetics cariprazine patient schizophrenia .</brief_summary>
	<brief_title>Long-term Study Cariprazine Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients correspond caregiver provide informed consent prior study specific procedure Patients currently meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criterion schizophrenia ( paranoid type , disorganize type , catatonic type undifferentiated type ) , confirm Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( SCID ) Patients normal physical examination , laboratory , vital sign electrocardiogram ( ECG ) Patients DSMIVTR diagnosis schizoaffective disorder , schizophreniform disorder , bipolar I bipolar II disorder , psychotic disorder schizophrenia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Acute Schizophrenia</keyword>
	<keyword>Psychotropic Drugs</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Dopamine Agents</keyword>
	<keyword>Central Nervous System Agents</keyword>
</DOC>